Literature DB >> 10320623

A comparison of re-infection rates with Schistosoma haematobium following chemotherapy in areas with high and low levels of infection.

F Mutapi1, P D Ndhlovu, P Hagan, M E Woolhouse.   

Abstract

Two groups of children (6-15 years) from a Schistosoma haematobium endemic area were followed for 9 months after praziquantel treatment. Seventy-three children came from an area of high infection while 67 children came from an area of low infection. Pre-treatment infection prevalence in the high infection area (76.6%) was significantly higher than that in low infection area (36.3%). Levels of anti-SEA immunoglobulin (Ig)A and IgM were significantly higher and levels of IgG3 significantly lower in children from the low infection area. Nine months after treatment, infection prevalence was significantly higher in the high infection area (29.0%) (where re-infection rates were higher) than in the low infection area (12.9%). Children from the high infection area were six times more likely to get re-infected than those from the low infection area, while younger children were 30 times more likely to get re-infected than older children. These results are discussed in relation to differences in transmission and the development of acquired immunity. Pre-treatment levels of IgM and the difference between IgE and IgG4 were positively associated with re-infection in the high infection area. These results are discussed in relation to the interpretation of simple correlations between infection and some antibody levels and the inference of causal relationships between observed epidemiological and immunological patterns.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320623     DOI: 10.1046/j.1365-3024.1999.00227.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  10 in total

1.  Prevalence and Reinfection Rates of Schistosoma mansoni and Praziquantel Efficacy against the Parasite among Primary School Children in Sanja Town, Northwest Ethiopia.

Authors:  Eden Woldegerima; Abebe Genetu Bayih; Yalewayker Tegegne; Mulugeta Aemero; Ayalew Jejaw Zeleke
Journal:  J Parasitol Res       Date:  2019-04-24

Review 2.  Immunology of human schistosomiasis.

Authors:  D G Colley; W E Secor
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

3.  Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.

Authors:  Muhubiri Kabuyaya; Moses John Chimbari; Tawanda Manyangadze; Samson Mukaratirwa
Journal:  Infect Dis Poverty       Date:  2017-04-07       Impact factor: 4.520

4.  Using the hierarchical ordinal regression model to analyse the intensity of urinary schistosomiasis infection in school children in Lusaka Province, Zambia.

Authors:  Christopher Simoonga; Lawrence N Kazembe
Journal:  Infect Dis Poverty       Date:  2017-02-21       Impact factor: 4.520

5.  A systematic review and meta-analysis on the rate of human schistosomiasis reinfection.

Authors:  Abdallah Zacharia; Vivian Mushi; Twilumba Makene
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

6.  Assessment of awareness and knowledge of schistosomiasis among school-aged children (6-13 years) in the Okavango Delta, Botswana.

Authors:  Kebabonye P Gabaake; Nthabiseng A Phaladze; Don Eliseo Lucero-Prisno Iii; Olekae T Thakadu
Journal:  Glob Health Res Policy       Date:  2022-09-30

7.  Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.

Authors:  Claire D Bourke; Norman Nausch; Nadine Rujeni; Laura J Appleby; Kate M Mitchell; Nicholas Midzi; Takafira Mduluza; Francisca Mutapi
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

Review 8.  Host determinants of reinfection with schistosomes in humans: a systematic review and meta-analysis.

Authors:  Evaristus Chibunna Mbanefo; Nguyen Tien Huy; Anita Akpeedje Wadagni; Christine Ifeoma Eneanya; Obioma Nwaorgu; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11

9.  Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment.

Authors:  Michael W Melkus; Loc Le; Arif J Siddiqui; Adebayo J Molehin; Weidong Zhang; Samra Lazarus; Afzal A Siddiqui
Journal:  Front Cell Infect Microbiol       Date:  2020-02-24       Impact factor: 5.293

Review 10.  Current Understanding of Immunity Against Schistosomiasis: Impact on Vaccine and Drug Development.

Authors:  Adebayo J Molehin
Journal:  Res Rep Trop Med       Date:  2020-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.